Cwm, LLC Regenxbio Inc. Transaction History
Cwm, LLC
- $28.4 Billion
- Q2 2025
A detailed history of Cwm, LLC transactions in Regenxbio Inc. stock. As of the latest transaction made, Cwm, LLC holds 46,816 shares of RGNX stock, worth $411,512. This represents 0.0% of its overall portfolio holdings.
Number of Shares
46,816
Previous 26,696
75.37%
Holding current value
$411,512
Previous $191,000
101.05%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding RGNX
# of Institutions
182Shares Held
45.5MCall Options Held
64.9KPut Options Held
103K-
Black Rock Inc. New York, NY8.61MShares$75.7 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA4.79MShares$42.1 Million3.6% of portfolio
-
Jpmorgan Chase & CO New York, NY4.36MShares$38.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.47MShares$30.5 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.07MShares$18.2 Million0.0% of portfolio
About REGENXBIO Inc.
- Ticker RGNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,230,000
- Market Cap $380M
- Description
- REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...